Association between time in range 70-180mg/dl in early stage and severity in patients with acute pancreatitis

Author:

Meng Chuchen1,Zhang Jie1,Wang Ying1,Ye Xinhua1,Zhuang Shaohua1

Affiliation:

1. Changzhou No.2 People's Hospital

Abstract

Abstract Background: It is not well understood whether glucose control in the early stage of acute pancreatitis(AP) is related to the outcome. This study aimed to investigate the association between blood glucose time in range (TIR) 70–180 mg/dL in the first 72 hours(h) on admission and the progression of AP. Methods: Patients admitted with AP to the gastroenterology department of Affiliated Changzhou No.2 People’s Hospital of Nanjing Medical University between Jan 2017 and Dec 2021 were included and retrospectively evaluated. The percentage of TIR between 70 and 180 mg/dL in the first 72 h was calculated. According to the progress of AP at discharge, the patients were divided into mild pancreatitis(MAP) and moderately severe acute pancreatitis (MSAP) or severe acute pancreatitis (SAP) group.We examined the association between TIR or TIR ≥70% and the severity of AP using logistic regression models with stratification by glycosylated hemoglobin (HbA1c) level of 6.5%. Receiver operating characteristic (ROC) curves were generated to assess the ability of TIR to predict MSAP or SAP. Results: A total of 298 patients were included and 35 of them developed into MSAP or SAP. Logistic regression analyses indicated that TIR was independently associated with the incidence of more serious AP(OR=0.962 95% CI=0.941-0.983, P=0.001). This association remained significant in patients with HbA1c ≤6.5% (OR=0.928 95%CI=0.888-0.969, P=0.001).TIR≥70% was independently associated with reduced severity only in patients with well-antecedent control (OR=0.238; 95% CI= 0.071-0.802; P =0.020). TIR was not powerful enough to predict the severity of AP in both patients with poor antecedent glucose control (AUC=0.641) or with HbA1c<6.5% (AUC=0.668). Conclusions :TIR was independently associated with severity in AP patients, particularly those with good antecedent glucose control.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3